Thrombosis unfurry
Thrombosis: a major contributor to the global disease burden
Iatrogenic anemia (can it be prevented?)
Twenty-five million liters of blood into the sewer
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment
Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study
No impact of endogenous prothrombotic conditions on the risk of central venous line-related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis)
Identification of APOH polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study
Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography – tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants
Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity
Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography–pulmonary angiography
C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts
The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood
Factor XIII stiffens fibrin clots by causing fiber compaction
Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells
Is plasminogen activator inhibitor type 2 really a plasminogen activator inhibitor after all?
Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice
A role for arginine-12 in thrombin–thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor
Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome
Multiplexed phosphospecific flow cytometry enables large-scale signaling profiling and drug screening in blood platelets
Guidance, guidelines, and communications
Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH
An international collaborative study to establish the World Health Organization 2nd International Standard for Factor VII Concentrate: communication from the SSC of the ISTH
Value assignment to the WHO 3rd International Standard for Blood Coagulation Fibrinogen Plasma (09/264): communication from the SSC of the ISTH
Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?: comment
Paternal factor V Leiden and recurrent pregnancy loss: a new concept behind fetal genetics?: reply